We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+77.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$83.8M
AUM Growth
-$9.56M
Cap. Flow
-$15.6M
Cap. Flow %
-18.56%
Top 10 Hldgs %
54.2%
Holding
117
New
40
Increased
13
Reduced
18
Closed
44

Top Buys

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$5.37M
2
SAGE
Sage Therapeutics
SAGE
+$2.54M
3
ITOS
iTeos Therapeutics
ITOS
+$2.43M
4
SKX
Skechers
SKX
+$2.07M
5
SGRY icon
Surgery Partners
SGRY
+$1.67M

Top Sells

Rank Stock Value
1
BUR icon
Burford Capital
BUR
+$3.92M
2
CLMT icon
Calumet Specialty Products
CLMT
+$2.55M
3
AMPY icon
Amplify Energy
AMPY
+$2.5M
4
LQDA icon
Liquidia Corp
LQDA
+$2.36M
5
PARR icon
Par Pacific Holdings
PARR
+$2.02M

Sector Composition

Rank Sector Weight
1 Healthcare 46.94%
2 Energy 12.53%
3 Real Estate 8.38%
4 Consumer Discretionary 7.77%
5 Materials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHCO
101
CALL
DELISTED
Soho House & Co
SHCO
– –
-1,400
Closed -$8.65K
NSLR
102
Neostellar Capital Corp
NSLR
$267M
– –
-14,950
Closed -$74.3K
SUP
103
DELISTED
Superior Industries International
SUP
– –
-100,533
Closed -$214K
SWTX
104
CALL
DELISTED
SpringWorks Therapeutics
SWTX
– –
-13,200
Closed -$583K
SWTX
105
DELISTED
SpringWorks Therapeutics
SWTX
– –
-33,400
Closed -$1.47M
TRIP icon
106
TripAdvisor
TRIP
$1.74B
– –
-45,009
Closed -$638K
TUSK icon
107
Mammoth Energy Services
TUSK
$129M
– –
-205,880
Closed -$420K
YPF icon
108
YPF
YPF
$19.6B
– –
-6,000
Closed -$210K
SMC
109
Summit Midstream
SMC
$410M
– –
-15,000
Closed -$508K
CEP
110
DELISTED
Cantor Equity Partners
CEP
– –
-26,482
Closed -$284K
AMTM
111
Amentum Holdings
AMTM
$5.73B
– –
-12,500
Closed -$228K
MAGN
112
Magnera Corp
MAGN
$502M
– –
-10,000
Closed -$182K
DRDB
113
Roman DBDR Acquisition Corp II
DRDB
$325M
– –
-89,167
Closed -$894K
DRDBW
114
Roman DBDR Acquisition Corp II Warrants
DRDBW
– –
-44,583
Closed -$447K
MLAC
115
DELISTED
Mountain Lake Acquisition Corp
MLAC
– –
-29,000
Closed -$291K
XIFR
116
XPLR Infrastructure LP
XIFR
$1.12B
– –
-12,200
Closed -$116K
FNA
117
DELISTED
Paragon 28, Inc.
FNA
– –
-50,000
Closed -$653K
1 2 3 4
5

Similar funds

EFT
Envision Financial Transparency Greensboro, North Carolina $103M AUM
GWL
Generations Wealth LLC Mason, Ohio $103M AUM
CC
Caspian Capital New York $103M AUM
ABLA
Alan B. Lancz & Associates Toledo, Ohio $103M AUM 31.99% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
OPAM
Olympus Peak Asset Management Greenwich, Connecticut $103M AUM 58.06% 1-Year Est. Return
ES
ETF Store Overland Park, Kansas $103M AUM 15.78% 1-Year Est. Return
IMT
Investment Management Trust Fitchburg, Massachusetts $103M AUM

Rangeley Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Rangeley Capital held 117 positions worth $83.8M, down 10% from $93.4M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Rangeley Capital withdrew a net $15.6M in Q2 2025, closing 44 positions and reducing 18 holdings. Its most notable exit was Liquidia Corp, an estimated $2.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 29% a quarter earlier, followed by Energy and Real Estate.

Against the trend, Rangeley Capital opened a new position in Prothena Corp worth $4.34M.

  • Rangeley Capital's largest Q2 2025 buy was Prothena Corp: 715,367 shares worth $4.34M.
  • Rangeley Capital added most to Sage Therapeutics in Q2 2025, an estimated $2.54M increase.
  • Rangeley Capital's biggest Q2 2025 reduction was Burford Capital, cutting an estimated $3.92M.
  • Rangeley Capital fully exited Liquidia Corp in Q2 2025, selling an estimated $2.36M.
  • Rangeley Capital's ten largest holdings make up 54% of its $83.8M portfolio in Q2 2025.
  • Rangeley Capital opened 40 new positions and closed 44 in Q2 2025.
  • Rangeley Capital's portfolio value fell 10% quarter-over-quarter to $83.8M.

Based on Rangeley Capital's 13F filing for Q2 2025, filed 14 Aug 2025.